Drugs / alcoholic chlorhexidine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01841242 | Apr 2013 → Jan 2021 | cardiac rhythm disease, heart failure | University Hospital of Saint-Etienne | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | alcoholic chlorhexidine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01841242 ↗ |
| Route | Topical | “One cutaneous application before implant procedure” NCT01841242 ↗ |